TOP > 外国特許検索 > URINARY BIOMARKER FOR USE IN TEST FOR PROSTATE CANCER

URINARY BIOMARKER FOR USE IN TEST FOR PROSTATE CANCER

外国特許コード F150008505
整理番号 3629
掲載日 2015年11月5日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2013JP059208
国際公開番号 WO 2013146997
国際出願日 平成25年3月28日(2013.3.28)
国際公開日 平成25年10月3日(2013.10.3)
優先権データ
  • 特願2012-078963 (2012.3.30) JP
発明の名称 (英語) URINARY BIOMARKER FOR USE IN TEST FOR PROSTATE CANCER
発明の概要(英語) Disclosed is a novel means which is non-invasive and enables a more highly accurate test for prostate cancer compared with the conventional test methods. The inventors of the present application intensively analyzed urine samples from prostate cancer patients and urine samples from non-cancer subject who are not suffering from prostate cancer. As a result, a urinary peptide that can serve as a measure for the test for prostate cancer was newly found. When the urinary peptide is used as a measure, it becomes possible to achieve various tests associated with prostate cancer, including the detection of prostate cancer, the discrimination between prostate cancer and benign prostatic hypertrophy, the monitoring for the therapeutic effect of a prostate cancer therapy and the monitoring for postoperative recurrence.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • KYOTO UNIVERSITY
  • 発明者(英語)
  • NAKAYAMA KENJI
  • SHIMIZU KAZUHARU
  • UTSUMI JUN
  • INOUE TAKAHIRO
  • OGAWA OSAMU
国際特許分類(IPC)
指定国 National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LA LC LK LR LS LT LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG
ライセンスをご希望の方、特許の内容に興味を持たれた方は、下記までご連絡ください。

PAGE TOP

close
close
close
close
close
close